Literature DB >> 1531085

Interaction of a common factor with ATF, Sp1, or TATAA promoter elements is required for these sequences to mediate transactivation by the adenoviral oncogene E1a.

S J Weintraub1, D C Dean.   

Abstract

The adenovirus protein E1a stimulates transcription of both viral and cellular genes. Unlike most other transcription factors, it induces transactivation through several different promoter elements. The mechanism by which elements of diverse sequence mediate the effect of E1a is the focus of this study. Three E1a-responsive elements (an ATF site, an Sp1 site, and a TATA box containing the sequence TATAA) were studied to determine whether their interaction with a common factor is necessary for transactivation. In transfection assays, each element was used as a competitor against promoter constructs containing the other elements. The elements as competitors had no effect on basal transcription, but each competitor completely inhibited transactivation by E1a. Competitors that were not E1a responsive failed to inhibit transactivation. Therefore, either E1a itself or an E1a-inducible factor interacts with each of the elements to cause transactivation, most likely though an association with each element's specific binding protein.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531085      PMCID: PMC364210          DOI: 10.1128/mcb.12.2.512-517.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  Cellular targets for transformation by the adenovirus E1A proteins.

Authors:  P Whyte; N M Williamson; E Harlow
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

2.  Transcription activation by the adenovirus E1a protein.

Authors:  J W Lillie; M R Green
Journal:  Nature       Date:  1989-03-02       Impact factor: 49.962

3.  Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism.

Authors:  E Pascal; R Tjian
Journal:  Genes Dev       Date:  1991-09       Impact factor: 11.361

4.  Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID.

Authors:  K F Stringer; C J Ingles; J Greenblatt
Journal:  Nature       Date:  1990-06-28       Impact factor: 49.962

5.  Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation.

Authors:  S Bagchi; P Raychaudhuri; J R Nevins
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

6.  A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins.

Authors:  C Murre; P S McCaw; D Baltimore
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

7.  Adenovirus early region 3 promoter regulation by E1A/E1B is independent of alterations in DNA binding and gene activation of CREB/ATF and AP1.

Authors:  M Kornuc; S Kliewer; J Garcia; D Harrich; C Li; R Gaynor
Journal:  J Virol       Date:  1990-05       Impact factor: 5.103

8.  Analysis of E1A-mediated growth regulation functions: binding of the 300-kilodalton cellular product correlates with E1A enhancer repression function and DNA synthesis-inducing activity.

Authors:  R W Stein; M Corrigan; P Yaciuk; J Whelan; E Moran
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

9.  Sequence-specific interactions between cellular DNA-binding proteins and the adenovirus origin of DNA replication.

Authors:  P J Rosenfeld; E A O'Neill; R J Wides; T J Kelly
Journal:  Mol Cell Biol       Date:  1987-02       Impact factor: 4.272

10.  Regulation of fibronectin biosynthesis by dexamethasone, transforming growth factor beta, and cAMP in human cell lines.

Authors:  D C Dean; R F Newby; S Bourgeois
Journal:  J Cell Biol       Date:  1988-06       Impact factor: 10.539

View more
  9 in total

1.  Functional domains of the human orphan receptor ARP-1/COUP-TFII involved in active repression and transrepression.

Authors:  G Achatz; B Hölzl; R Speckmayer; C Hauser; F Sandhofer; B Paulweber
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Domains A and B in the Rb pocket interact to form a transcriptional repressor motif.

Authors:  K N Chow; D C Dean
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

3.  The Rb family contains a conserved cyclin-dependent-kinase-regulated transcriptional repressor motif.

Authors:  K N Chow; P Starostik; D C Dean
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

4.  Transcription factor TFIID is a direct functional target of the adenovirus E1A transcription-repression domain.

Authors:  C Z Song; P M Loewenstein; K Toth; M Green
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

5.  CREB (cAMP response element binding protein) and C/EBPalpha (CCAAT/enhancer binding protein) are required for the superstimulation of phosphoenolpyruvate carboxykinase gene transcription by adenoviral E1a and cAMP.

Authors:  J M Routes; L A Colton; S Ryan; D J Klemm
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

6.  Vascular cell adhesion molecule 1: contrasting transcriptional control mechanisms in muscle and endothelium.

Authors:  M F Iademarco; J J McQuillan; D C Dean
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-01       Impact factor: 11.205

7.  Nerve Growth factor regulation of cyclin D1 in PC12 cells through a p21RAS extracellular signal-regulated kinase pathway requires cooperative interactions between Sp1 and nuclear factor-kappaB.

Authors:  Francesco Marampon; Mathew C Casimiro; Maofu Fu; Michael J Powell; Vladimir M Popov; Jaime Lindsay; Bianca M Zani; Carmela Ciccarelli; Genichi Watanabe; Richard J Lee; Richard G Pestell
Journal:  Mol Biol Cell       Date:  2008-03-26       Impact factor: 4.138

8.  Modulation of transcriptional activation of the proliferating cell nuclear antigen promoter by the adenovirus E1A 243-residue oncoprotein depends on proximal activators.

Authors:  G F Morris; C Labrie; M B Mathews
Journal:  Mol Cell Biol       Date:  1994-01       Impact factor: 4.272

9.  A novel application of E1A in combination therapy with EGFR-TKI treatment in breast cancer.

Authors:  Chih-Ming Su; Ting-Yu Chang; Hui-Ping Hsu; Hui-Huang Lai; Jie-Ning Li; Yu-Jhen Lyu; Kuang-Tai Kuo; Ming-Te Huang; Jen-Liang Su; Pai-Sheng Chen
Journal:  Oncotarget       Date:  2016-09-27
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.